Literature DB >> 32679152

Nephrotoxicity Associated With Niraparib.

Hélène Lazareth1, Nicolas Delanoy2, Raphaël Cohen3, Emilie Boissier2, Hamza Ayari3, Pierre Combe2, Céline Crespel2, Elise Mercadier-Riaz4, Alexandre Karras5, Marie Courbebaisse3, Eric Thervet5, Nicolas Pallet6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32679152     DOI： 10.1053/j.ajkd.2020.05.021

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  3 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology.

Authors:  Maaike A C Bruin; Gabe S Sonke; Jos H Beijnen; Alwin D R Huitema
Journal:  Clin Pharmacokinet       Date:  2022-10-11       Impact factor: 5.577

Review 2.  Prostate cancer and PARP inhibitors: progress and challenges.

Authors:  Diego Teyssonneau; Henri Margot; Mathilde Cabart; Mylène Anonnay; Paul Sargos; Nam-Son Vuong; Isabelle Soubeyran; Nicolas Sevenet; Guilhem Roubaud
Journal:  J Hematol Oncol       Date:  2021-03-29       Impact factor: 17.388

Review 3.  PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.

Authors:  Diego Teyssonneau; Antoine Thiery-Vuillemin; Charles Dariane; Eric Barret; Jean-Baptiste Beauval; Laurent Brureau; Gilles Créhange; Gaëlle Fiard; Gaëlle Fromont; Mathieu Gauthé; Alain Ruffion; Raphaële Renard-Penna; Romain Mathieu; Paul Sargos; Morgan Rouprêt; Guillaume Ploussard; Guilhem Roubaud
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.